Advertisement

Transmissible cerebral amyloidosis

Conference paper
Part of the Journal of Neural Transmission Supplement book series (NEURAL SUPPL, volume 47)

Summary

Transmissible cerebral amyloidosis occurs in three forms — sporadic, iatrogenic, and familial. Clinical and epidemiological aspects of sporadic disease are briefly described, followed by an up-to-date review of the increasing numbers and varieties of iatrogenic and mutation-positive familial cases.

Keywords

Prion Protein Fatal Familial Insomnia Prion Protein Gene Iatrogenic Disease Insert Mutation 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Bernoulli C, Siegfried J, Baumgartner G, Regli F, Rabinowics T, Gajdusek DC, Gibbs CJ Jr (1977) Danger of accidental person-to-person transmission of Creutzfeldt-Jakob disease by surgery. Lancet is 478–479Google Scholar
  2. Brown P (1994) Transmissible human spongiform encephalopathy (infectious cerebral amyloidosis): Creutzfeldt-Jakob disease, Gertmann-Sträussler-Scheinker syndrome, and kuru. In: Calne D (ed) Neurodegenerative disease. Saunders, Philadelphia, pp 839–876Google Scholar
  3. Brown P (1996) Environmental causes of human spongiform encephalopathy. In: Baker H, Ridley R (eds) Prion diseases. Humana Press, Totowa, NJ, pp 139–154CrossRefGoogle Scholar
  4. Brown P, Gajdusek DC, Gibbs CJJ, Asher DM (1985) Potential epidemic of Creutzfeldt-Jakob disease from human growth hormone therapy. N Engl J Med 313: 728–31PubMedCrossRefGoogle Scholar
  5. Brown P, Gibbs C Jr, Rodgers-Johnson P, Asher D, Sulima M, Bacote A, Goldfarb L, Gajdusek D (1994) Human spongiform encephalopathy: the National Institutes of Health series of 300 cases of experimentally transmitted disease. Ann Neurol 35: 513–529PubMedCrossRefGoogle Scholar
  6. Brown P, Goldfarb L, Cervenâkovâ L, McCombie W, Scalici C, Masullo C, Graupera G, Ligan J, Gajdusek D (1994) Iatrogenic Creutzfeldt-Jakob disease: an example of the interplay between ancient genes and modern medicine. Neurology 44: 291–293PubMedGoogle Scholar
  7. Chapman J, Arlazoroff A, Cervenâkovâ L, Goldfarb L, Neufeld M, Werber E, Brown P, Gajdusek D, Korczyn A (1996) Fatal familial insomnia in a case of familial Creutzfeldt-Jakob disease with the codon 200LYS mutation. Neurology 46: 758–761PubMedGoogle Scholar
  8. Collinge J, Palmer MS, Dryden AJ (1991) Genetic predisposition to iatrogenic Creutzfeldt-Jakob disease. Lancet 337: 1441–1442PubMedCrossRefGoogle Scholar
  9. Creutzfeldt HG (1920) Über eine eigenartige herdförmige Erkrankung des Zentralnervensystems. Z Ges Neurol Psychiat 57: 1–18CrossRefGoogle Scholar
  10. Deslys J, Marcé D, Dormont D (1994) Similar genetic susceptibility in iatrogenic and sporadic Creutzfelt-Jakob disease. J Gen Virol 75: 23–27PubMedCrossRefGoogle Scholar
  11. Dlouhy SF, Hsiao K, Farlow MR, Foroud T, Conneally PM, Johnson P, Prusiner SB, Hodes ME, Ghetti B (1992) Linkage of the Indiana kindred of Gerstmann-SträusslerScheinker disease to theprion protein gene. Nature Genet 1: 64–67PubMedCrossRefGoogle Scholar
  12. Duffy P, Wolf J, Collins G, DeVoe AG, Streeten B, Cowen D (1974) Possible personto-person transmission of Creutzfeldt-Jakob disease. N Engl J Med 290: 692PubMedGoogle Scholar
  13. Foncin J, Gaches J, Cathala F, El Sherif E, Le Beau J (1980) Transmission iatrogène interhumaine possible de maladie de Creutzfeldt-Jakob avec atteinte des grains du cervelet. Rev Neurol (Paris) 136: 280Google Scholar
  14. Gajdusek DC, Zigas V (1957) Degenerative disease of the central nervous system in New Guinea: epidemic occurrence of “kuru” in the native population. N Engl J Med 257: 974–978PubMedCrossRefGoogle Scholar
  15. Gerstmann J (1928) Über ein noch nicht beschriebenes Reflexphänomen bei einer Erkrankung des zerebellaren Systems. Wien Med Wochenschr 78: 906–908Google Scholar
  16. Goldfarb L, Brown P (1994) The transmissible spongiform encephalopathies. Ann RevMed 46: 57–65CrossRefGoogle Scholar
  17. Goldfarb LG, Brown P, Vrbovskâ A, Baron H, McCombie WR, Cathala F, Gibbs CJ Jr, Gajdusek DC (1992) An insert mutation in the chromosome 20 amyloid precursor gene in a Gerstmann-Sträussler-Scheinker family. J Neurol Sci 111: 189–194PubMedCrossRefGoogle Scholar
  18. Goldfarb LG, Petersen RB, Tabaton M, Brown P, LeBlanc AC, Montagna P, Cortelli P, Julien J, Vital C, Pendelbury WW, Haltia M, Wills PR, Hauw JJ, McKeever PE, Monari L, Schrank B, Swergold GD, Autilio-Gambetti L, Gajdusek DC, Lugaresi E, Gambetti P (1992) Fatal familial insomnia and familial CreutzfeldtJakob disease: disease phenotype determined by a DNA polymorphism. Science 258: 806–808PubMedCrossRefGoogle Scholar
  19. Goldfarb LG, Brown P, Haltia M, Ghiso J, Frangione B, Gajdusek DC (1993) Synthetic peptides corresponding to different mutated regions of the amyloid gene in familial Creutzfeldt-Jakob disease show enhanced in vitro formation of morphologically distinct amyloid fibrils. Proc Natl Acad Sci (USA) 90: 4451–4454CrossRefGoogle Scholar
  20. Hainfellner J, Brantner-Inthaler S, Cervenâkovâ L, Brown P, Kitamoto T, Tateishi J, Diringer H, Liberski P, Regele H, Feucht M, Mayr N, Wessely P, Summer K, Seitelberger F, Budka H (1995) The original Gerstmann-Sträussler-Scheinker family of Austria: divergent clinicopathological phenotypes but constant PrP genotype. Brain Pathol 11: 201–213CrossRefGoogle Scholar
  21. Hitoshi S, Nagura H, Yamanouchi H, Kitzmoto T (1993) Double mutations at codon 180 and codon 232 of the PRNP gene in an apparently sporadic case of Creutzfeldt-Jakob disease. J Neurol Sci 120: 208–212PubMedCrossRefGoogle Scholar
  22. Hsiao K, Baker HF, Crow TJ, Poulter M, Owen F, Terwilliger JD, Westaway D, Ott J, Prusiner SB (1989) Linkage of a prion protein missense variant to GerstmannSträussler syndrome. Nature 338: 342–245PubMedCrossRefGoogle Scholar
  23. Hsiao KK, Dlouhy SR, Farlow MR, Cass C, Da Costa M, Conneally PM, Hodes ME, Ghetti B, Prusiner SB (1992) Mutant prion proteins in Gerstmann-SträusslerScheinker disease with neurofibrillary tangles. Nature Genet 1: 68–71PubMedCrossRefGoogle Scholar
  24. Jakob A (1923) Spastische Pseudosklerose. In: Foerster O, Wilmanns K (eds) Monographien aus dem Gesamtgebiete der Neurologie und Psychiatrie. Springer, Berlin, pp 215–245Google Scholar
  25. Kirschbaum W (1924) Zwei eigenartige Erkrankungen des Zentralnervensystems nach Art der spastischen Pseudosklerose (Jakob). Z Ges Neurol Psychiat 92: 175–202CrossRefGoogle Scholar
  26. Kitamoto T, Amano N, Terao Y, Nakazato Y, Isshiki T, Mizutani T, Tateishi J (1993) A new inherited prion disease (PrP-P105L mutation) showing spastic paraparesis. Ann Neurol 34: 808–813PubMedCrossRefGoogle Scholar
  27. Kitamoto T, Iizuka R, Tateishi J (1993) An amber mutation of prion protein in Gerstmann-Sträussler-syndrome with mutant PrP plaques. Biochem Biophys Res Commun 192: 525–531PubMedCrossRefGoogle Scholar
  28. Kretzschmar HA, Honold G, Seitelberger F, Feucht M, Wessely P, Mehraein P, Budka H (1991) Prion protein mutation in family first reported by Gerstmann, Sträussler, and Scheinker. Lancet 337: 1160PubMedCrossRefGoogle Scholar
  29. Lugaresi E, Medori R, Montagna P, Baruzzi A, Cortelli P, Lugaresi A, Tinuper P, Zucconni M, Gambetti P (1986) Fatal familial insomnia and dysautonomia with selective degeneration of thalamic nuclei. N Engl J Med 315: 997–1003PubMedCrossRefGoogle Scholar
  30. Masters CL, Harris JO, Gajdusek DC, Gibbs CJ Jr, Bernoulli C, Asher DM (1979) Creutzfeldt-Jakob disease: patterns of world wide occurrence and the significance of familial and sporadic clustering. Ann Neurol 5: 177–188PubMedCrossRefGoogle Scholar
  31. Mastrianni JA, Iannicola C, Myers R, Prusiner SB (1995) Identification of a new mutation of the prion protein gene at codon 208 in a patient with Creutzfeldt-Jakob disease (Abstract). Ann Neurol 45 [Suppl 4]: A201Google Scholar
  32. Owen F, Poulter M, Lofthouse R, Collinge J, Crow TJ, Risby D, Baker HF, Ridley RM, Hsiao K, Prusiner SB (1989) Insertion in prion protein gene in familial CreutzfeldtJakob disease. Lancet 1: 51–52PubMedCrossRefGoogle Scholar
  33. Pocchiari M, Salvatore M, Cutruzzolâ F, Genuardi M, Allocatelli CT, Masullo C, Macchi G, Aléma G, Galgani S, Xi YG, Petraroli R, Silverstrini MC, Brunori M (1993) A new point mutation of the prion protein gene in Creutzfeldt-Jakob disease. Ann Neurol 34: 802–807PubMedCrossRefGoogle Scholar
  34. Raubertas R, Brown P, Cathala F, Brown I (1989) The question of clustering of Creutzfeldt-Jakob disease. Am J Epidemiol 129: 146–154PubMedGoogle Scholar
  35. Thadani V, Penar PL, Partington J, Kalb R, Janssen R, Schonberger LB, Rabkin CA, Prichard JW (1988) Creutzfeldt-Jakob disease probably acquired from a cadaveric dura mater graft. J Neurosurg 69: 766–769PubMedCrossRefGoogle Scholar
  36. Tranchant C, Doh-Ura K, Steinmetz G, Chevalier Y, Kitamoto T, Tateishi J, Warter JM (1991) Mutation du codon 117 du gène du prion dans une maladie de GerstmannSträussler-Scheinker. Rev Neurol (Paris) 147: 274–278Google Scholar
  37. Wientjens D, Davinipour Z, Hofman A, Kondo K, Matthews B, Will R, van Duijn C (1996) Risk factors for Creutzfeldt-Jakob disease: a re-analysis of case-control studies. Neurology (in press)Google Scholar
  38. Will RG, Matthews WB (1982) Evidence for case-to-case transmission of Creutzfeldt Jakob disease. J Neurol Neurosurg Psychiatry 45: 235–238PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag 1996

Authors and Affiliations

  • P. Brow
    • 1
  1. 1.Laboratory of CNS Studies, National Institute of Neurological Disorders and StrokeNational Institutes of HealthBethesdaUSA

Personalised recommendations